Technical Analysis: 19 October 2018 By Violeta Todorova 19 October 2018, 8:43 AM Cooper Energy, REA Group, Aust Securities Exchange and Ramsay Health Care. Read more...
BHP Billiton: Scalable upcycle By Adrian Prendergast 19 October 2018, 7:39 AM Sustained capital discipline and healthy demand fundamentals have delivered a potentially extended upcycle in resources, with BHP our top pick. Read more...
Rio Tinto: Strategy shifting gears By Adrian Prendergast 18 October 2018, 2:45 PM We maintain our Add rating Read more...
Technical Analysis: 18 October 2018 By Violeta Todorova 18 October 2018, 9:25 AM Sydney Airport, Emeco Holdings, Saracen Mineral, St Barbara and Evolution Mining. Read more...
Technical Analysis: 15 October 2018 By Violeta Todorova 15 October 2018, 8:06 AM Westpac Banking Corp, Commonwealth Bank, ANZ Banking Group, National Australia Bank and Macquarie Group. Read more...
Podcast: How to tell between a bear market and a bull market correction By Michael Knox 12 October 2018, 10:47 AM We are now in a bull market correction. Read more...
Technical Analysis: 12 October 2018 By Violeta Todorova 12 October 2018, 9:43 AM Spot Gold, Wesfarmers and Fortescue Metals Group. Read more...
SEEK: On track By Ivor Ries 12 October 2018, 7:42 AM Despite signs of softening in new job postings, SEEK remains on track to fulfill guidance expectations for FY19. Read more...
An Update on COVID-19 Vaccine Development By Raymond Chan 24 April 2020, 12:00 AM 新冠肺炎疫苗真可快將面世？ 世界各地法寶盡出，奮力對抗新型冠狀病毒肺炎這個共同「敵人」，可惜迄今為止只能拖慢疫情擴散的速度，顯得治標不治本。其實，大家都明白到，若要成功戰勝新冠肺炎，唯一最有效的方法就是成功研發出疫苗。 很大程度上要感謝中國，在疫情初期就分享了新冠肺炎病毒的基因排序，目前已經有至少60種候選新冠肺炎疫苗，正在經由多間藥廠、生物科技公司和研究機構進行試驗 抗疫最強「武器」 臨床試驗階段 目前為止，美國生物科技公司 Moderna Therapeutics 所研發的疫苗 mRNA-1273，是最讓各方人士期盼的抗疫最強「武器」。此疫苗已經在美國華盛頓州進行臨床試驗，用於此次疫情中的高危群體，例如是前線醫護人員 澳洲的科研人員也不甘後人，現正加快進行大規模的人體測試，觀察過去幾十年以來一直用於治療肺結核病的現成疫苗，能否有效地保護前線醫護人員免受新冠肺炎感染。臨床測試中的新冠肺炎疫苗 Bacillus Calmette-Guerin（簡稱BCG），將會用於分布在澳洲全國各地的4,000位醫院前線醫護人員，務求從中了解此疫苗能否有效地紓緩新冠肺炎的病徵 BCG疫苗原本是用於對付... Read more...
Zip Co: AGM and capital raising By Richard Coles 03 December 2019, 12:00 AM Zip Co (ASX:Z1P) has announced a A$60m capital raising in conjunction with its AGM. While we are supportive of Z1P's growth plans, the current capital raising does add to significant dilution throughout CY19 which needs to be justified by execution. Read more...